Development of New Drugs to Treat Infectious Diseases
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Antimicrobial Agents and Resistance".
Deadline for manuscript submissions: 20 May 2025 | Viewed by 989
Special Issue Editor
Special Issue Information
Dear Colleagues,
Infectious diseases constitute a serious global health concern. The increasing prevalence and spread of antimicrobial resistance, high mortality rates in hospital-acquired infections, and lack of adequate treatments for several “neglected tropical diseases”, particularly in developing countries, are points that deserve special attention from the international scientific community and the World Health Organization. Furthermore, the COVID-19 pandemic has highlighted the importance of advancing studies for developing novel prophylactic and therapeutic strategies for viral infections. In this context, it is essential to develop new effective and safe pharmacological therapies to treat infections caused by viruses, bacteria, fungi, and protozoa. This Special Issue, entitled "Development of New Drugs to Treat Infectious Diseases", aims to present recent research on different aspects of the field, providing a broad scientific platform for scientists performing fundamental, applied and translational research related to the development of new drugs to treat infectious diseases. Some focal points include, but are not limited to, the following:
- Target-based drug discovery and development of novel antimicrobial agents.
- Host-directed strategies.
- Drug repurposing for infectious diseases.
- Natural products as sources of anti-infective compounds.
- Target characterization and validation.
- Preclinical efficacy studies.
- Toxicity investigations.
- Pharmacokinetics and pharmacodynamics.
- Computational approaches for anti-infective drug design.
- Combination therapy strategies.
Reviews, original research, and communications will be welcome.
Dr. Valnês da Silva Rodrigues-Junior
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial agents
- natural products
- tropical diseases
- therapeutic strategies
- viral infections
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
